José Luis Zugaza Gurruchaga-rekin lankidetzan egindako argitalpenak (4)

2020

  1. An overview of international regulatory frameworks for mesenchymal stromal cell-based medicinal products: From laboratory to patient

    Medicinal Research Reviews, Vol. 40, Núm. 4, pp. 1315-1334

  2. Small gtpases of the ras and rho families switch on/off signaling pathways in neurodegenerative diseases

    International Journal of Molecular Sciences, Vol. 21, Núm. 17, pp. 1-23

2019

  1. Principal criteria for evaluating the quality, safety and efficacy of hMSC-based products in clinical practice: Current approaches and challenges

    Pharmaceutics, Vol. 11, Núm. 11

2016

  1. Mesenchymal Stem Cells as Therapeutics Agents: Quality and Environmental Regulatory Aspects

    Stem Cells International, Vol. 2016